| Name | Title | Contact Details |
|---|
Emerging Travel is an online travel group that operates four brands in 100+ source markets: RateHawk, ZenHotels, Ostrovok.ru, and B2B.Ostrovok. Our products help customers select and book all types of accommodation from over 1,2mn+ options in 220 countries.
StackBlitz is a browser-based integrated development environment (IDE) for web development that allows users to create secure, instantly reproducible, fullstack dev environments which boot in milliseconds.
TripLingo was founded in 2011 as a solution to the numerous language and cultural barriers that international business travelers often confront. Since then, the app has expanded to include smart travel features—like currency conversion, local emergency numbers, general safety information, and essential medical terminology. In 2013, TripLingo was selected by GBTA as the “Business Travel Innovation of the Year.”
Heartland Payment Systems, Inc. is a US-based payment processing and technology provider.
Businesses are finding themselves faced with transformative change, from cloud technology to big data. No better example than the life sciences industry which is transforming from a data-driven clinical enterprise to an information-driven one. As the EDC specialists OmniComm understands the power that an information-driven clinical enterprise can bring to your clinical research organization. OmniComm is the only company that provides our clients with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated. We bring the most advanced open and interoperable EDC platforms to our clients; through our innovative cloud technology and advanced API web services we provide our clients with information to make insight driven clinical data-based critical decisions, bringing medical therapies to patients faster with lower risk. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. 4 of the 5 top CROs and 7 of the 10 largest Phase I Clinics run OmniComm EDC technologies.